Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system

Neuroscience

Volumn 97, Issue 1, 2000, Pages 155-170

  Alonso, G ^a   Phan, V L ^a   Guillemain, I ^a   Saunier, M ^a   Legrand, A ^a   Anoal, M ^a   Maurice, T ^a  

^a INSERM   (France)

Author keywords

Electron microscopy; Immunolocalization; Polyclonal antibody; Rat brain; Sigma1 ( 1) receptor

Indexed keywords

POLYCLONAL ANTIBODY; RECEPTOR ANTIBODY; SIGMA 1 OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN VENTRICLE; CAUDATE NUCLEUS; CELL MEMBRANE; CENTRAL GRAY MATTER; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DENDRITE; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; EPENDYMA CELL; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MITOCHONDRION; MOTONEURON NUCLEUS; NERVE CELL; NONHUMAN; OLFACTORY BULB; PERIKARYON; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PUTAMEN; RAT; RHOMBENCEPHALON; SEPTUM NUCLEUS; SPINAL CORD; SPINAL CORD DORSAL HORN; TISSUE DISTRIBUTION;

ANIMALS; BLOTTING, WESTERN; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; EPENDYMA; FLUORESCENT ANTIBODY TECHNIQUE; MALE; MICROSCOPY, ELECTRON; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECEPTORS, SIGMA;

EID: 0034034280     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00014-2     Document Type: Article

References (41)

1. Bouchard P., Dumont Y., Fournier A., St.Pierre S., Quirion R. Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation. J. Neurosci. 13:1993;3926-3931.
2. Bouchard P., Roman F., Junien J.L., Quirion R. Autoradiographic evidence for the modulation of in vivo sigma receptor labeling by neuropeptide Y and calcitonin gene-related peptide in the mouse brain. J. Pharmac. exp. Ther. 276:1996;223-230.
3. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience. 15:1985;1159-1181.
4. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system I. Radioimmunoassay and chromatographic characterisation. Neuroscience. 18:1986;527-543.
5. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system II. Immunohistochemical analysis. Neuroscience. 18:1986;545-618.
6. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J. Neurosci. 6:1986;1757-1770.
7. 1-binding site. Proc. natn. Acad. Sci. U.S.A. 93:1996;8072-8077.
8. 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmac. 268:1994;9-18.
9. Itzhak Y., Alerhand S. Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice. Fedn Am. Socs exp. Biol. J. 3:1989;1868-1872.
10. Itzhak Y., Stein I. Sigma binding sites in the brain: an emerging concept for multiple sites and their relevance for psychiatric disorders. Life Sci. 47:1990;1073-1081.
11. 1 sites. Eur. J. Pharmac. 299:1996;21-28.
12. Kekuda R., Prasad P.D., Fei Y.J., Leibach F.H., Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem. biophys. Res. Commun. 229:1996;553-558.
13. Knight A.R., Noble A., Wong E.H.F., Middlemiss D.N. The subcellular distribution and pharmacology of the sigma recognition site in the guinea-pig brain and liver. Molec. Neuropharmac. 1:1991;77-82.
14. Kohler C., Eriksson L., Davies S., Chan-Palay V. Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J. comp. Neurol. 244:1986;384-400.
15. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
16. 3H]-1-[1-(2- thienyl)cyclohexyl]piperidine. J. Pharmac. exp. Ther. 238:1986;739-748.
17. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmac. exp. Ther. 197:1976;517-532.
18. 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur. J. Pharmac. 312:1996;267-271.
19. Matsuno K., Matsunaga K., Mita S. Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis. Brain Res. 575:1992;315-319.
20. Maurice T., Lockhart B.P. Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands. Prog. Neuropsychopharmac. biol. Psychiat. 21:1997;69-102.
21. McCann D.J., Rabin R.A., Rens-Domiano S., Winter J.C. Phencyclidine/SKF-10,047 binding sites: evaluation of function. Pharmac. Biochem. Behav. 32:1989;87-94.
22. 3H]SKF-10,047 binding sites (σ sites) exhibit a unique distribution in rat brain subcellular fractions. Eur. J. Pharmac. 188:1990;211-218.
23. 3H]SKF-10,047 binding sites (σ sites) from rat liver membranes. J. Pharmac. exp. Ther. 257:1991;547-554.
24. 2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns. Synapse. 17:1994;182-189.
25. McLean S., Weber E. Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain. Neuroscience. 25:1988;259-269.
26. 7 isomerase. Br. J. Pharmac. 121:1997;1-6.
27. 3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn-Schmiedeberg's Arch. Pharmac. 346:1992;32-39.
28. Monnet F.P., Debonnel G., de Montigny C. Neuropeptide Y selectively potentiates N-methyl-D-aspartate-induced neuronal activation. Eur. J. Pharmac. 182:1990;207-208.
29. Monnet F.P., Debonnel G., Junien J.L., De Montigny C. N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors. Eur. J. Pharmac. 179:1990;441-445.
30. 1 receptor. J. Neurochem. 70:1998;2279-2285.
31. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends pharmac. Sci. 13:1992;85-86.
32. Quirion R., Chicheportiche R., Contreras P.C., Johnson K.M., Lodge D., Tam S.W., Woods J.H., Zukin S.R. Classification and nomenclature of phencyclidine and σ receptor sites. Trends pharmac. Sci. 10:1987;444-446.
33. Seth P., Fei Y.J., Li H.W., Huang W., Leibach F.H., Ganapathy V. Cloning and functional characterization of a σ receptor from rat brain. J. Neurochem. 70:1998;922-931.
34. Seth P., Leibach F.H., Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem. biophys. Res. Commun. 241:1997;535-540.
35. Siniscalchi A., Cristofori P., Veratti E. Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors. Naunyn-Schmiedeberg's Arch. Pharmac. 336:1987;425-429.
36. 1 receptor antisense studies. Soc. Neurosci. Abstr. 24:1998;2055.
37. Su T.-P. and Junien J.-L. (1994) Sigma receptors in the central nervous system and the periphery. In Sigma Receptors (ed. Itzhak Y.), pp. 21-44. Academic, San Diego.
38. Taylor D.P., Dekleva J. Potential antipsychotic BMY-14802 selectively binds to sigma sites. Drug dev. Res. 11:1987;65-70.
39. Ujike H., Kanzaki A., Okumura K., Akiyama K., Otsuki S. Sigma (σ) antagonist BMY-14802 prevents methamphetamine-induced sensitization. Life Sci. 50:1992;PL129-PL134.
40. Vaupel D.B. Naltrexone fails to antagonize the sigma effects of PCP and SKF-10,047 in the dog. Eur. J. Pharmac. 9:1983;269-274.
41. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Sigma receptors: biology and function. Pharmac. Rev. 42:1990;355-402.